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The reaction of N-phenylimidoyl isoselenocyanates 1 with 2-amino-1,3-thiazoles 10 in 
acetone proceeded smoothly at room temperature to give 4H-1,3-thiazolo[3,2-
a][1,3,5]triazine-4-selones 13 in fair yields (Scheme 2). Under the same conditions, 1 and 2-
amino-3-methylpyridine (11) underwent an addition reaction followed by a spontaneous 
oxidation to yield the 3H-4λ4-[1,2,4]selenadiazolo[1',5':1,5][1,2,4]selenadiazolo[2,3-
a]pyridine 14 (Scheme 3). The structure of the latter was established by X-ray crystallography 
(Figure). Finally, the reaction of 1-methylimidazole (12) and 1 led to 1-methyl-3-(N-
phenylbenzimidoyl)imidazolium selenocyanates 15 (Scheme 4). In all three cases, an initially 
formed selenourea derivative is proposed as an intermediate. 
 
 
 
 
3 
 
Introduction. – The interest in selenium-containing organic compounds is unbroken, 
mainly because of their biological activities [1][2]. For this reason, convenient syntheses of 
selenaheterocycles and heterocyclic selones are much sought after. In recent years, the use of 
isoselenocyanates as easily accessible and safe building blocks has been demonstrated 
successfully [3]. Among them, the imidoyl derivatives of type 1, which can be prepared 
conveniently from N-phenylimidoyl chlorides and potassium selenocyanate [4][5] are of 
special interest because of their bifunctional nature.  
We have shown that the reaction of 1 with primary or secondary amines leads to 
selenourea derivatives, which by subsequent reaction with activated bromomethylene 
compounds and treatment with a strong base yield 2-amino-1,3-selenazoles 2 [5] (Scheme 1). 
Imidoyl isoselenocyanates 1 with R1 = 2-(chloromethyl)phenyl react with amines to give 6H-
5,1,3-benzoselenadiazocines 3 [6]. In both cases, the initial reaction is a nucleophilic attack of 
the amine onto the isoselenocyanate, followed by an addition of the intermediate thiourea 
derivative with an electrophile in an inter- or intramolecular fashion. With amidines 4 and 6, 
respectively, 1,3,5-triazineselones 5 and 7 are formed smoothly at room temperature [7] 
(Scheme 1). Similarly, 2-amino-4,5-dihydro-1,3-thiazole (8) reacts with 1 to give the fused 
triazineselones 9. The formation of the triazineselones 5, 7, and 9 has been rationalized by the 
initial formation of a selenourea derivative, followed by cyclization and elimination of aniline 
(Ar2 = Ph). 
 
Scheme 1 
 
The goal of the present study was the extension of the reaction of 1 with amidines to 
aromatic 2-aminoazaheterocycles, such as 2-amino-1,3-thiazoles 10 and 2-aminopyridines 11, 
i.e., aromatic heterocycles with a formal amidine group, as well as to 1-methylimidazole (12). 
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Results and Discussion. – The starting materials, i.e., N-phenylbenzimidoyl 
isoselenocyanates 1a – 1c were prepared as described in [5]. In acetone at room temperature, 
they underwent a smooth reaction with equimolar amounts of 2-amino-1,3-thiazoles 10a and 
10b, respectively, to give 4H-1,3-triazolo[3,2-a][1,3,5-triazine-4-selones 13 in 53 – 63% yield 
(Scheme 2, Table 1). The products precipitated directly from the reaction mixture as orange-
yellow solids. Their structure was derived from the spectroscopic data, the elemental analyses, 
and by analogy to the earlier described 6,7-dihydro derivative 9 (Ar1 = 4-ClC6H4), the 
structure of which has been established by X-ray crystallography [7]2)
 
. The formation of 13 
can be rationalized as shown in Scheme 2: nucleophilic addition of the ring N-atom of 10 to 
the isoselenocyanate 1 leads to the intermediate selenourea derivative B, which spontaneously 
undergoes cyclization to give the fused ring system C. Elimination of aniline from the latter 
yields the product 13. 
Scheme 2 
 
Table 1. Prepared 2-Aryl-4H-1,3-thiazolo[3,2-a][1,3,5]triazine-4-selones 13 
 
The next experiment was carried out with 2-amino-3-methylpyridine (11) and 1c. It is 
worth mentioning that the reaction in acetone also occurred at room temperature. After 
                                                 
2)  The analogous reaction of phenylbenzimidoyl isothiocyanate with 10a has been described 
by Barnikov and Ebeling [8]. Furthermore, 2-aryl-4H-1,3-thiazolo[3,2-a][1,3,5]triazine-4-
thiones have been obtained in the reaction of 10a with aroyl isothiocyanates, which were 
prepared in situ from aroyl chlorides and NH4SCN [9]. On the other hand, 10a and 
alkoxycarbonyl isothiocyanates reacted in a non-selective manner via nucleophilic 
addition of either the NH2 group or the ring N-atom [10].  
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stirring for 3 h, the mixture was poured into H2O leading to a yellowish, crystalline product in 
ca. 65% yield. The NMR spectra indicated clearly that no aniline was eliminated, and also the 
elemental analyses were in accordance with a 1:1 adduct. Therefore, the structure of the 
selenourea derivative D was proposed (Scheme 3). Surprisingly, the 1H-NMR spectrum as 
well as the CI-MS (NH3) showed that two H-atoms were missing. For this reason, a crystal-
structure determination of the product was undertaken confirming that 2-(4-chlorophenyl)-9-
methyl-3-phenyl-3H-4λ4-[1,2,4]selenadiazolo[1',5':1,5][1,2,4]selenadiazolo[2,3-a]pyridine 
(14) was formed (Fig. 1).  
 
Scheme 3 
 
Fig. 1. ORTEP plot [11] of the molecular structure of 14 (50% probability ellipsoids, 
arbitrary numbering of the atoms) 
 
The Se-atom appears to be three-coordinated in that it receives two dative bonds, one 
from the N-atom of the pyridine ring and the other from the N-atom adjacent to the 
unsubstituted Ph group.  These N–Se bonds are asymmetric, differing by about 0.12 Å, and 
they are 0.08-0.20 Å longer than the C–Se bond.  A normal N–Se single bond is about 1.85 Å, 
which is in the range of 0.15-0.27 Å shorter than the N–Se bonds seen here.  The C–Se bond 
(1.918(2) Å) is about 0.10 Å longer than the C=Se double bond found in an analog of 13c [7], 
which is consistent with the effect induced by the N–Se interactions and is indicative of 
partial delocalisation of the electron density in this bond.  Similar C–Se bond lengths of about 
1.90 Å have been observed in some related structures [12], where a formal C–Se single bond 
is adjacent to a π-system.  The dative bonds complete two fused five-membered rings.  The 
bond lengths around these rings show considerable delocalisation of all C–N bonds and the 
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C–Se bond, which probably implies the existence of canonical forms of a resonance structure.  
None of the N-atoms in the structure are protonated, which is consistent with the NMR 
spectra. 
 
 The two five-membered rings are quite planar with the maximum deviation from the 
mean plane being 0.053(2) Å for C(7).  This plane is nearly coplanar with that of the fused 
six-membered ring, the angle between the planes being only 5.09(9)°.  If the three fused rings 
are considered together, the maximum deviation from the mean plane is 0.095(2) Å for N(2).  
The planes of the chlorophenyl ring and the remaining phenyl ring make angles of 18.8(1)° 
and 75.39(9)°, respectively, with the mean plane of the two fused five-membered rings.   
The unexpected formation of 14 may be explained by the initial addition of the amino 
N-atom of 11 onto the isoselenocyanate yielding the intermediate selenourea D. A 
spontaneous oxidation leads then to the isolated product. In contrast to the reactions with 10, 
in which the ring N-atom was the most nucleophilic center, the NH2 group of 11 acted as 
nucleophile. This observation may be rationalized by the higher aromaticity of the pyridine 
ring compared with that of the 1,3-thiazole ring. 
Finally, 1-methylimidazole (12), with a formal amidine structure integrated in the five-
membered ring, was reacted with 1b and 1c, respectively, in acetone. The reaction also 
proceeded at room temperature. After stirring the mixture overnight, it was poured into H2O, 
and the formed precipitate was recrystallized from AcOEt. The elemental analyses showed 
that the molecular formulae of the products 15b and 15c correspond with the sum of the 
respective starting materials, i.e., no elimination of aniline occurred. The NMR spectra also 
indicated clearly the presence of all expected H- and C-atoms, e.g. in the case of 15b, two 
signals for Me groups appeared at 4.19/37.7 and 2.36/21.5 ppm. Most remarkable was a 
singlet for one H-atom at 9.30 ppm attached to C(2) of the imidazole ring (136.9 ppm). 
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Furthermore, the most dominant absorption band in the IR spectrum (KBr) appeared at 2061 
cm–1. On the basis of extended NMR investigations (HSQC, 1H/13C and 1H/15N HMBC, 
TOCSY, and NOESY), the structures of 1-methyl-3-(N-phenylbenzimidoyl)imidazolium 
selenocyanates 15b and 15c were proposed (Scheme 4). 
 
Scheme 4 
 
The three N-atoms of the 3-(benzimidoyl)imidazolium moiety of 15c were 
undoubtedly localized at –202.4 (N(1)), –177.1 (N(3)), and –72.9 ppm (C=N) (Fig. 2). They 
showed the expected HMBC correlations with the H-atoms of the imidazolium ring as well as 
the ortho-H-atoms of the Ph ring. E.g., N(1) shows correlations with H–C(2) at 9.35 ppm, H–
C(4) at 7.81 ppm, H–C(5) at 7.67 ppm, and Me–N(1) at 4.18 ppm, whereas N(3) correlates 
with H–C(2), H–C(4), and H–C(5). The correlations of the imidoyl N-atom with the ortho-H-
atoms of Ph and the imidoyl C-atom with the ortho-H-atoms of 4-ClC6H4 are indicative of the 
molecular structure. The H–C group absorbing at remarkably low field (9.35/137.1 ppm) is 
attributed to HC(2) of the imidazolium ring. The characteristic values for the selenocyanate 
ion are 117.8 (13C) and –129.2 ppm (15N). All these chemical shifts as well as the IR 
absorption for the NCSe– ion are in very good agreement with the data of the recently studied 
ionic liquid 3-butyl-1-methylimidazolium selenocyanate (16, Fig. 2) [13]. 
 
Fig. 2. Selected 1H-, 13C-, and 15N-NMR shifts of 15c in CDCl3 (in ppm) 
 
A reaction mechanism for the unexpected formation of 15 is proposed in Scheme 4. 
The first step, in analogy to the reaction of 2-amino-1,3-thiazoles 10 (Scheme 2), may be the 
nucleophilic addition of imidazole 12 to the isoselenocyanate 1 to give a zwitterionic 
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intermediate I. The latter undergoes a cyclization to give the fused triazineselone derivative L, 
which then forms a new zwitterion L via ring opening. Subsequent ring closure may form the 
fused 1,3-diazetidine M, which, via elimination of NCSe–, leads to the isolated imidazolium 
salt.  
 
Conclusions. – The presented results extend the knowledge on reactions of amidines 
with imidoyl isoselenocyanates 1 to heterocycles containing an ‘amidine-like’ structure 
moiety. The reaction of 2-amino-1,3-thiazoles 10 parallels those with amidines and, most 
likely, can be extended further to similar five-membered 2-aminoheterocycles such as 2-
amino-1,3-oxazoles, 2-aminoimidazoles, etc. We believe that all the reactions proceed via 
initial nucleophilic attack of the ring N-atom of the 2-aminoheterocycle at the most 
electrophilic heterocumulene C-atom, in contrast to the mechanism formulated for the 
analogous reaction with aroyl isothiocyanates [9]. On the other hand, the NH2 group of 2-
aminopyridine (11) is the most nucleophilic center in the reaction with 1, leading to a 
selenourea derivative, which undergoes a spontaneous oxidation. Again a different type of 
product is formed in the reaction with 1-methylimidazole (12), in which the initially formed 
adduct cannot stabilize and, therefore, undergoes a sequence of further reactions to give the 
imidazolium salts.  
In conclusion, isoselenocyanates 1 are prone to react with various ‘amidine-like’ 
molecules leading to new Se-containing heterocycles, a reaction type, which is worth to be 
studied further. 
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Experimental Part 
 
1. General. Thin layer chromatography (TLC) on silica gel 60 F254 plates (0.25 mm, 
Merck); hexane/AcOEt 1:1 or 2:1 as eluents. Column chromatography (CC) on silica gel 60 
(0.040–0.063 mm; Merck). Melting points (m.p.): Büchi B-540 apparatus; in capillary, 
uncorrected. IR spectra: Perkin-Elmer-Spektrum 1600 FT-IR spectrophotometer; in KBr, in 
cm–1. 1H-NMR (300 or 600 MHz), 13C-NMR (75 or 150 MHz), and 15N-NMR (60.6 MHz) 
spectra: Bruker ARX-300 or AMX-600 instrument, in CDCl3; chemical shifts in ppm (rel. to 
TMS (1H, 13C) or MeNO2 (15N)), coupling constants J in Hz. The multiplicities of 13C signals 
were determined with DEPT spectra. EI-MS (70 eV) and CI-MS (NH3 as carrier gas): 
Finnigan MAT-95 or Finnigan SSQ-700 instrument; ESI-MS: Finnigan TSQ-700. Elemental 
analyses were carried out on a Gerber Elementar Analysator EL instrument.  
2. Starting Materials. The preparation of N-phenylimidoyl isoselenocyanates 1a – 1c 
has been described in [5]. All other starting materials, 10a, 10b, 11, and 12, were 
commercially available (Fluka, Sigma-Aldrich) and were used without purification. 
3. Reactions of 1 with 2-Amino-1,3-thiazoles 10. To a stirred soln. of 1 (3 – 4.5 mmol) 
in acetone (20 ml) at r.t. was added the equivalent amount of 10. Immediately, a yellow to 
orange precipitate formed. The mixture was stirred at r.t. for 1 h, the formed precipitate was 
filtered under vacuum, washed with some acetone, and dried in vacuum. The products were 
recrystallized from acetone or DMF. 
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2-Phenyl-4H-1,3-thiazolo[3,2-a][1,3,5]triazine-4-selone (13a). Yield: 0.53 g (53%); 
from 878 mg (3.4 mmol) 1a, 340 mg (3.4 mmol) 10a. Orange crystals. M.p. 281.4 – 282.4° 
(acetone/DMF). IR (KBr): 3095m, 1548m, 1538m, 1513s, 1492m, 1456s, 1391vs, 1346m, 
1325vs, 1296vs, 1279m, 1255s, 1164w, 1130m, 1093m, 1072w, 1022w, 999w, 978w, 942w, 
892m, 848s, 800w, 756w, 716s, 693s. 1H-NMR (300 MHz, CDCl3): 8.93 (d, J = 4.9, 1 H); 
8.61 – 8.57 (m, 2 arom. H); 7.64 – 7.57 (m, 1 arom. H); 7.53 – 7.48 (m, 2 arom. H); 7.32 (d, J 
= 4.9, 1 H). 13C-NMR (75 MHz, CDCl3): 179.4 (s, C=Se); 167.5, 160.3 (2s, C(2), C(8a)); 
133.1 (s, 1 arom. C); 133.6, 130.5, 128.8 (3d, 5 arom. CH); 128.6, 112.9 (2d, C(5), C(6)). EI-
MS: 295 (5), 294 (3), 293 (22, M+), 291 (10), 290 (4), 289 (4), 188 (13), 187 (100), 104 (8), 
103 (15), 84 (14), 77 (70). Anal. calc. for C11H7N3SSe (292.22): C 45.21, H 2.41, N 14.38, S 
10.97; found: C 45.26, H 2.40, N 14.38, S 10.96. 
2-(4-Methylphenyl)-4H-1,3-thiazolo[3,2-a][1,3,5]triazine-4-selone (13b). Yield: 0.60 
g (59%); from 987 mg (3.3 mmol) 1b, 330 mg (3.3 mmol) 10a. Yellow crystals. M.p. 295 – 
296° (acetone). IR (KBr): 3131w, 3039m, 1604w, 1572w, 1536s, 1521vs, 1506s, 1422s, 
1392vs, 1328s, 1300s, 1292s, 1254s, 1176w, 1166m, 1122m, 1016w, 892m, 845s, 790w, 
772m, 740s, 711w. CI-MS: 310 (20), 309 (13), 308 (100, [M+1]+), 307 (8), 306 (48), 305 (16), 
304 (16). Anal. calc. for C12H9N3SSe (306.25): C 47.06, H 2.96, N 13.72, S 10.47; found: C 
47.04, H 3.07, N 13.63, S 10.46. 
2-(4-Chlorophenyl)-4H-1,3-thiazolo[3,2-a][1,3,5]triazine-4-selone (13c). Yield: 0.59 
g (58%); from 991 mg (3.1 mmol) 1c, 310 mg (3.1 mmol) 10a. Yellow crystals. M.p. 280° 
(dec., acetone). 1H-NMR (300 MHz, CDCl3): 8.92 (d, J = 4.9, 1 H); 8.53, 7.47 (AA’BB’, JAB = 
8.9, 4 arom. H); 7.31 (d, J = 4.9, 1 H). 13C-NMR (75 MHz, CDCl3): 179.4 (s, C=Se); 167.6, 
159.3 (2s, C(2), C(8a)); 140.2, 130.5 (2s, 2 arom. C); 131.7, 129.1 (2d, 4 arom. CH); 128.6, 
113.0 (2d, C(5), C(6)). Anal. calc. for C11H6ClN3SSe (326.67): C 40.45, H 1.85, N 12.86, S 
9.82; found: C 40.26, H 2.04, N 12.83, S 9.96. 
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7-Methyl-2-phenyl-4H-1,3-thiazolo[3,2-a][1,3,5]triazine-4-selone (13d). Yield: 0.60 g 
(58%); from 878 mg (3.4 mmol) 1a, 388 mg (3.4 mmol) 10b. Orange crystals. M.p. 280 – 
281° (acetone/DMF). IR (KBr): 3101w, 3053w, 3031w, 2967w, 1587m, 1518vs, 1492m, 
1456s, 1401vs, 1384vs, 1341s, 1326s, 1298m, 1273m, 1256s, 1182m, 1137m, 1100m, 1080m, 
1021w, 996w, 941w, 879m, 838s, 807m, 743s, 693m. 1H-NMR (300 MHz, CDCl3): 8.66 (q-
like, J = 1.4, 1 H); 8.56 – 8.54 (m, 2 arom. H); 7.62 – 7.51 (m, 1 arom. H); 7.49 – 7.46 (m, 2 
arom. H); 2.53 (d, J = 1.4, Me). 13C-NMR (75 MHz, CDCl3): 178.7 (s, C=Se); 167.1, 160.0 
(2s, C(2), C(8a)); 133.9, 127.1 (2s, 1 arom. C, C(7)); 133.4, 130.4, 128.7 (3d, 5 arom. CH); 
126.8 (d, C(6)); 13.5 (q, Me). EI-MS: 309 (12), 308 (8), 307 (55, M+), 305 (27), 304 (10), 303 
(9), 202 (13), 201 (100), 198 (15), 197 (14). Anal. calc. for C12H9N3SSe (306.25): C 47.06, H 
2.96, N 13.72, S 10.47; found: C 46.99, H 2.83, N 13.85, S 10.63. 
7-Methyl-2-(4-methylphenyl)-4H-1,3-thiazolo[3,2-a][1,3,5]triazine-4-selone (13e). 
Yield: 0.93 g (63%); from 1.376 g (4.6 mmol) 1b, 524 mg (4.6 mmol) 10b. Orange-yellow 
crystals. M.p. 291° (dec., DMF). IR (KBr): 3074m, 2933w, 1606w, 1589m, 1573w, 1530vs, 
1508s, 1456m, 1420s, 1393vs, 1359s, 1333s, 1298s, 1275s, 1257s, 1179m, 1140s, 1111m, 
1100m, 1018w, 992w, 877m, 848s, 852w, 836s, 764s. CI-MS: 324 (21), 323 (15), 322 (100, 
[M+1]+), 321 (8), 320 (49), 319 (17), 318 (17), 258 (7). Anal. calc. for C13H11N3SSe (320.28): 
C 48.75, H 3.46, N 13.12, S 10.01; found: C 48.58, H 3.37, N 13.07, S 10.11. 
7-Methyl-2-(4-chlorophenyl)-4H-1,3-thiazolo[3,2-a][1,3,5]triazine-4-selone (13f). 
Yield: 0.65 g (62%); from 991 mg (3.1 mmol) 1c, 353 mg (3.1 mmol) 10b. Orange crystals. 
M.p. 282.0 – 282.5° (DMF). 1H-NMR (300 MHz, CDCl3): 8.65 (q-like, J = 1.4, 1 H); 8.50, 
7.46 (AA’BB’, JAB = 8.7, 4 arom. H); 2.54 (d, J = 1.4, Me). 13C-NMR (75 MHz, CDCl3): 
179.0 (s, C=Se); 168.0, 158.0 (2s, C(2), C(8a)); 140.2, 132.2, 127.5 (3s, 2 arom. C, C(7)); 
131.5, 129.0 (2d, 4 arom. CH); 126.7 (d, C(6)); 13.4 (q, Me). EI-MS: 343 (17), 342 (6), 341 
(38, M+), 340 (5), 339 (17), 338 (6), 337 (6), 268 (23), 253 (45), 237 (37), 236 (12), 235 
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(100). Anal. calc. for C12H8ClN3SSe (340.69): C 42.31, H 2.37, N 12.33, S 9.41; found: C 
42.10, H 2.29, N 12.26, S 9.27. 
4. Reaction of 1c with 2-Amino-3-methylpyridine (11). To a stirred soln. of 1c (992 mg, 3.1 
mmol) in acetone (20 ml) at r.t., one equivalent of 11 (335 mg, 3.1 mmol) was added, and the 
mixture was stirred for 3 h, until the starting materials were completely consumed (TLC). 
Then, the mixture was poured into H2O and stirred for another 1 h. The yellowish precipitate 
was filtered under vacuum and recrystallized from Et2O to give 0.85 g (64%) of 2-(4-
chlorophenyl)-9-methyl-3-phenyl-3H-4λ4-[1,2,4]selenadiazolo[1',5':1,5][1,2,4]selenadiazo-
lo[2,3-a]pyridine (14). M.p. 189.5 – 190.5. IR: 3041w, 2955w, 2948w, 1605w, 1592w, 1567w, 
1511s, 1463s, 1445m, 1401s, 1367vs, 1319m, 1300m, 1286s, 1274s, 1223m, 1196s, 1125m, 
1104m, 1089m, 1071w, 1015m, 992w, 951m, 892w, 838m, 778m, 765w, 748m, 734m. 1H-
NMR (300 MHz, CDCl3): 8.24 (dd-like, J = 8.7, 0.8, 1 H); 7.63 – 7.54 (m, 3 H); 7.35 – 7.20 
(m, 5 H); 7.08 – 7.04 (m, 2 H); 6.84 (dd-like, J = 7.0, 5.8, 1 H); 2.64 (s, Me). 13C-NMR (75 
MHz, CDCl3): 174.4 (s, C=Se); 162.2, 156.4, 141.2, 136.2, 131.0, 130.5 (6s, 3 arom. C, 3 C); 
137.0, 135.0, 126.2, 115.4 (4d, 1 arom. CH, 3 CH); 131.5, 129.3, 128.1, 125.5 (4d, 8 arom. 
CH); 17.5 (q, Me). CI-MS: 430 (5), 429 (38), 428 (19), 427 (100, [M+1]+), 426 (13), 425 (46), 
424 (15), 423 (15), 349 (14), 347 (25), 233 (13), 231 (41), 136 (7), 134 (12). Anal. calc. for 
C20H15ClN4Se (425.78): C 56.42, H 3.55, N 13.16, Cl 8.33; found: C 56.00, H 3.66, N 12.97, 
Cl 8.50. 
Suitable crystals for the X-ray crystal-structure determination were obtained from 
Et2O/AcOEt. 
5. Reactions of 1 with 3-Methylimidazole (12). To a soln. of 1b (987 mg, 3.3 mmol) or 
1c (895 mg, 2.8 mmol) in acetone (30 ml), one equivalent of 12 (271 mg and 230 mg, resp.) 
was added, and the mixture was stirred at r.t. overnight. TLC indicated that the starting 
materials were completely consumed. Then, the mixture was poured into ice/H2O and stirred 
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for another 2 h. The yellowish precipitate was filtered under vacuum and recrystallized from 
AcOEt.  
1-Methyl-3-(N-phenyl-4-methylbenzimidoyl)imidazolium selenocyanate (15b): Yield: 
0.66 g (52%). Pale yellow crystals. M.p. 116.5 – 117.5° (AcOEt). IR: 3181w, 3083m, 2061vs, 
1654s, 1608m, 1583s, 1537s, 1509w, 1484m, 1449w, 1417m, 1333s, 1272m, 1233s, 1211m, 
1189m, 1143s, 1088m, 1023w, 927s, 907w, 831m, 794w, 766m, 727m, 695s. 1H-NMR (600 
MHz, CDCl3): 9.30 (br. s, H–C(2)(imid)); 7.78 – 7.76, 7.74 – 7.72 (2m, 2 H(imid)); 7.33 – 
7.27 (m, 2 arom. H); 7.27 – 7.15 (m, 4 arom. H); 7.12 – 7.02 (m, 1 arom. H); 6.84 – 6.78 (m, 2 
arom. H); 4.19 (s, MeN); 2.36 (s, Me). 13C-NMR (150 MHz, CDCl3): 148.7 (s, C=N); 145.2, 
142.8, 123.8 (3s, 3 arom. C); 136.9 (d, C(2)H(imid)); 130.2, 129.6, 129.0, 121.2 (4d, 2 arom. 
CH each); 125.5 (d, 1 arom. CH); 124.5, 119.8 (2d, 2 CH(imid)); 117.6 (s, NCSe); 37.7 (q 
MeN); 21.5 (q, Me). 15N-NMR (60.6 MHz, CDCl3): –205.3 (N(1)); –178.3 (N(3)); –78.6 
(C=N)3)
1-Methyl-3-(N-phenyl-4-chlorobenzimidoyl)imidazolium selenocyanate (15c): Yield: 
0.62 g (55%). Pale yellow crystals. M.p. 144° (dec., AcOEt). IR: 3140m, 3071s, 2060vs, 
1672vs, 1594s, 1532s, 1489s, 1449w, 1415m, 1402m, 1359m, 1332m, 1274m, 1256s, 1214w, 
1180w, 1142s, 1110m, 1089s, 1015m, 927s, 904w, 838m, 778w, 765m, 741s, 699s. 1H-NMR 
(600 MHz, CDCl3): 9.34 (br. s, H–C(2)(imid)); 7.82 – 7.80, 7.68 – 7.60 (2m, 2 H(imid)); 7.48 
– 7.39 (m, 4 arom. H); 7.28 – 7.20 (m, 2 arom. H); 7.11 – 7.06 (m, 1 arom. H); 6.83 – 6.79 (m, 
2 arom. H); 4.17 (s, MeN). 13C-NMR (150 MHz, CDCl3): 147.6 (s, C=N); 144.8, 138.4, 125.2 
(3s, 3 arom. C); 137.1 (d, C(2)H(imid)); 131.3, 129.8, 129.1, 121.1 (4d, 2 arom. CH each); 
125.7 (d, 1 arom. CH); 124.5, 119.7 (2d, 2 CH(imid)); 117.6 (s, NCSe); 37.7 (q MeN). 15N-
NMR (60.6 MHz, CDCl3): –202.4 (N(1)); –177.1 (N(3)); –129.2 (NCSe); –72.9 (C=N). Anal. 
. Anal. calc. for C19H18N4Se (381.34): C 59.84, H 4.76, N 14.69; found: C 59.71, H 
4.76, N 14.61. 
                                                 
3)  The signal for NCSe– could not be detected. 
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calc. for C18H15ClN4Se (401.76): C 53.81, H 3.76, Cl 8.82, N 13.95; found: C 53.71, H 3.79, 
Cl 8.94, N 13.82.7.  
X-Ray Crystal-Structure Determination of 14 (Table and Fig. 1)4)
 
. All measurements 
were performed on a Rigaku AFC5R diffractometer using graphite-monochromated MoKα 
radiation (λ 0.71073 Å) and a 12kW rotating anode generator. The data collection and 
refinement parameters are given in the Table, and a view of the molecule is shown in the 
Figure. The intensities were corrected for Lorentz and polarization effects. An empirical 
absorption correction based on azimuthal scans of several reflections [14] was applied. The 
structure was solved by direct methods using SIR92 [15], which revealed the positions of all 
non-H-atoms. The non-H-atoms were refined anisotropically. The H-atoms were placed in 
geometrically calculated positions and refined using a rigid model where each H-atom was 
assigned a fixed isotropic displacement parameter with a value equal to 1.2Ueq of its parent 
atom. Refinement of the structure was carried out on F2 using full-matrix least-squares 
procedures, which minimized the function Σw(Fo2 – Fc2)2. A correction for secondary 
extinction was not applied. Neutral atom scattering factors for non-H-atoms were taken from 
[16a], and the scattering factors for H-atoms were taken from [17]. Anomalous dispersion 
effects were included in Fc [18]; the values for f ' and f " were those of [16b]. The values of 
the mass attenuation coefficients are those of [16c]. All calculations were performed using the 
SHELXL97 program [19]. 
Table 2. Crystallographic Data for Compound 14 
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Legends 
 
Fig. 1. ORTEP Plot [10] of the molecular structure of 14 (50% probability ellipsoids, 
arbitrary numbering of the atoms) 
 
 
Fig. 2. Selected 1H-, 13C-, and 15N-NMR shifts of 15c in CDCl3 (in ppm) 
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Table 1. Prepared 2-Aryl-4H-1,3-thiazolo[3,2-a][1,3,5]triazole-4-selones 13 
 
1 10 13  Yield (%) 
a Ar = Ph a R = H a Ar = Ph, R = H  53 
b Ar = 4-MeC6H4 a R = H b Ar = 4-MeC6H4, R = H 60 
c Ar = 4-ClC6H4 a R = H c Ar = 4-ClC6H4, R = H 60 
a Ar = Ph b R = Me d Ar = Ph, R = Me 57 
b Ar = 4-MeC6H4 b R = Me e Ar = 4-MeC6H4, R = Me 63 
c Ar = 4-ClC6H4 b R = Me f Ar = 4-ClC6H4, R = Me 63 
 
 
 
Table 2.  Crystallographic Data for Compound 14 
__________________________________________________________________________________ 
  
Crystallized from Et2O/AcOEt  
Empirical formula C20H15ClN4Se  
Formula weight 425.72  
Crystal color, habit yellow, prism  
Crystal dimensions [mm] 0.30 × 0.35 × 0.45  
Temperature [K] 173(1)  
Crystal system triclinic  
Space group P
_
,1  
Z 2  
Reflections for cell determination 25  
2θ range for cell determination [°] 39 – 40  
Unit cell parameters a [Å] 9.021(1)  
 b [Å] 9.503(1)  
 c [Å] 10.849(2) 
 α [°] 86.66(1) 
 β [°] 76.76(1) 
 γ [°] 89.33(1) 
 V [Å3] 903.7(3)  
20 
 
Dx [g cm–1] 1.564  
µ(MoKα) [mm–1] 2.235   
Scan type ω/2θ 
2θ(max) [°] 60 
Transmission factors (min; max) 0.867; 1.000  
Total reflections measured 5584  
Symmetry independent reflections 5290  
Reflections with I > 2σ(I) 4284  
Parameters refined 236  
Final  R(F) [I > 2σ(I) reflections] 0.0362   
 wR(F2) (all data) 0.0973  
Weighting  parameters: a, ba) 0.053, 0.1553  
Goodness of fit 1.056  
Final ∆max/σ 0.003  
∆ρ (max; min) [e Å
–3
] 0.84; –0.79  
 
 
a) w–1 = [σ 2(Fo2) + (aP)2 + bP], where P = (Fo2 + 2Fc2)/3
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N N
Ar
+
1c (Ar = 4-ClC6H4)
Ph
C
Se
11
Acetone
r.t.
N
Ph
N
H
N
Ar
H
N
Se N
Me
Se N
NN
N
Ph
Me
Cl
14
Me
H2N
D
Ar
H
N
N
H
N
Se N
Me
D'
Ph
Oxidation
 
 
Scheme 4 
N N
Ar
+
1b Ar = 4-MeC6H4
  c Ar = 4-ClC6H4
Ph
C
Se
12
Acetone
r.t.
15b R = Me
    c R = Cl
N
N
Me
N
N
Me
N Ar
Ph
N
C
Se
N
N
Me
Se
N
N
Ar
Ph
I
N
N
Me
K
N
N
Se
Ph
Ar
H H
N
N
Me
N
Ar
N C Se
H
N
N
Me
H
N
Ph
Ar
N
C
Se
L
M
Ph
 
23 
 
 
Figure 1 
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Graphical Abstract 
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